We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study (CMV-IMPACT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01077908
First Posted: March 1, 2010
Last Update Posted: October 30, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Wellcome Trust
EMAS Pharma
Commitum AB
BioAnaLab
Information provided by (Responsible Party):
Cell Medica Ltd
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)